Optiscan Imaging Ltd
Company Profile
Business description
Optiscan Imaging Ltd is engaged in the development, manufacture and commercialisation of proprietary confocal imaging devices and digital solutions for surgical, pathology and veterinary applications. Activities included the advancement of the company's InVueTM, InFormTM and InSpectaTM platforms through product development, clinical studies, regulatory activities, strategic collaborations and commercialisation initiatives. The group operated predominantly in the confocal microscope industry. It has presence in Germany, China, Australia, and United States. Majority of revenue comes from Germany. Its products are Optiscan InVueTM, Optiscan InFormTM, Optiscan InVivage, Optiscan ViewnVivo, and Optiscan InSpectaTM.
Contact
16 Miles Street
Mulgrave
MelbourneVIC3170
AUST: +61 395983333
Sector
Technology
Stock type
Sensitive
Industry
Scientific & Technical Instruments
Fiscal Year End
Employees
33
Stocks News & Analysis
stocks
The 10 best US companies to invest in now
stocks
Surge in combat drones drives upgrade for ASX share
stocks
Meta: Meta launches enterprise offering to open up another way to monetize AI investments
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,886.10 | 31.40 | 0.35% |
| CAC 40 | 7,897.19 | 61.88 | 0.79% |
| DAX 40 | 25,231.20 | 291.85 | 1.17% |
| Dow JONES (US) | 51,176.96 | 250.40 | 0.49% |
| FTSE 100 | 10,461.95 | 33.68 | 0.32% |
| HKSE | 23,929.35 | 42.94 | -0.18% |
| NASDAQ | 27,190.86 | 319.27 | 1.19% |
| Nikkei 225 | 69,993.34 | 1,683.88 | 2.47% |
| NZX 50 Index | 13,661.08 | 19.41 | -0.14% |
| S&P 500 | 7,722.72 | 56.27 | 0.73% |
| S&P/ASX 200 | 8,712.10 | 30.00 | 0.35% |
| SSE Composite Index | 3,842.19 | 11.74 | 0.31% |